Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elisabeth Schaffner-Reckinger

Showing results (1-10 of 24) with videos related to

Pageof 3
Sort By:
Bulletin De La Societe Des Sciences Medicales Du Grand-Duche De Luxembourg|November 17, 2004
Beta3 integrins: major therapeutic targets of the near futureElisabeth Schaffner-Reckinger
European Journal of Cell Biology|March 21, 2006
RGD, the Rho'd to cell spreadingAlexandre Salsmann, Elisabeth Schaffner-Reckinger, Nelly Kieffer
International Review of Cell and Molecular Biology|August 30, 2020
The actin-bundling protein L-plastin-A double-edged sword: Beneficial for the immune response, maleficent in cancerElisabeth Schaffner-Reckinger, Raquel A C Machado
Npj Drug Discovery|July 1, 2026
Drugging Ras trafficking-are there new roads to travel?Elisabeth Schaffner-Reckinger, Atanasio Gómez-Mulas, Daniel Kwaku Abankwa
Biochemical Society Transactions|January 23, 2023
Eliminating oncogenic RAS: back to the future at the drawing boardCandy Laura Steffen, Pelin Kaya, Elisabeth Schaffner-Reckinger, et al.
The Biochemical Journal|November 17, 2025
The impact of RAS on cell differentiation in health and diseaseCarla Jane Duval, Sara Bottone, Elisabeth Schaffner-Reckinger, et al.
The Journal of Biological Chemistry|June 16, 2005
A new functional role of the fibrinogen RGD motif as the molecular switch that selectively triggers integrin alphaIIbbeta3-dependent RhoA activation during cell spreadingAlexandre Salsmann, Elisabeth Schaffner-Reckinger, Fabrice Kabile, et al.
Plos One|May 26, 2017
The PET and LIM1-2 domains of testin contribute to intramolecular and homodimeric interactionsStefano Sala, Marie Catillon, Ermin Hadzic, et al.
Pharmaceuticals (Basel, Switzerland)|February 26, 2022
Bruceine D Identified as a Drug Candidate against Breast Cancer by a Novel Drug Selection Pipeline and Cell Viability AssayClaudia Cipriani, Maria Pires Pacheco, Ali Kishk, et al.
Cell Communication and Signaling : CCS|February 23, 2021
L-plastin Ser5 phosphorylation is modulated by the PI3K/SGK pathway and promotes breast cancer cell invasivenessRaquel A C Machado, Dunja Stojevski, Sébastien De Landtsheer, et al.
Pageof 3

Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
Bulletin De La Societe Des Sciences Medicales Du Grand-Duche De Luxembourg|November 17, 2004
Beta3 integrins: major therapeutic targets of the near futureElisabeth Schaffner-Reckinger
European Journal of Cell Biology|March 21, 2006
RGD, the Rho'd to cell spreadingAlexandre Salsmann, Elisabeth Schaffner-Reckinger, Nelly Kieffer
International Review of Cell and Molecular Biology|August 30, 2020
The actin-bundling protein L-plastin-A double-edged sword: Beneficial for the immune response, maleficent in cancerElisabeth Schaffner-Reckinger, Raquel A C Machado
Npj Drug Discovery|July 1, 2026
Drugging Ras trafficking-are there new roads to travel?Elisabeth Schaffner-Reckinger, Atanasio Gómez-Mulas, Daniel Kwaku Abankwa
Biochemical Society Transactions|January 23, 2023
Eliminating oncogenic RAS: back to the future at the drawing boardCandy Laura Steffen, Pelin Kaya, Elisabeth Schaffner-Reckinger, et al.
The Biochemical Journal|November 17, 2025
The impact of RAS on cell differentiation in health and diseaseCarla Jane Duval, Sara Bottone, Elisabeth Schaffner-Reckinger, et al.
The Journal of Biological Chemistry|June 16, 2005
A new functional role of the fibrinogen RGD motif as the molecular switch that selectively triggers integrin alphaIIbbeta3-dependent RhoA activation during cell spreadingAlexandre Salsmann, Elisabeth Schaffner-Reckinger, Fabrice Kabile, et al.
Plos One|May 26, 2017
The PET and LIM1-2 domains of testin contribute to intramolecular and homodimeric interactionsStefano Sala, Marie Catillon, Ermin Hadzic, et al.
Pharmaceuticals (Basel, Switzerland)|February 26, 2022
Bruceine D Identified as a Drug Candidate against Breast Cancer by a Novel Drug Selection Pipeline and Cell Viability AssayClaudia Cipriani, Maria Pires Pacheco, Ali Kishk, et al.
Cell Communication and Signaling : CCS|February 23, 2021
L-plastin Ser5 phosphorylation is modulated by the PI3K/SGK pathway and promotes breast cancer cell invasivenessRaquel A C Machado, Dunja Stojevski, Sébastien De Landtsheer, et al.
Pageof 3